Different systemic rheumatic diseases as risk factors for COVID-19-related mortality

Area of Science:

• Rheumatology
• Infectious Diseases
• Epidemiology

Background:

• COVID-19 has led to significant global morbidity and mortality.
• The increased mortality risk in patients with systemic rheumatic diseases (SRDs) due to COVID-19 is still under investigation.
• Existing nationwide studies suggest a potential increase in adverse COVID-19 outcomes and mortality among SRD patients.

Purpose of the Study:

• To address the ongoing debate regarding COVID-19-related mortality in patients with SRDs.
• To highlight the need for an individualized approach in assessing COVID-19 risks for SRD patients.
• To emphasize the importance of considering disease-specific factors in risk stratification.

Main Methods:

• Review of existing nationwide studies on COVID-19 outcomes in SRD patients.
• Analysis of factors influencing COVID-19 mortality in SRD populations.
• Discussion of the need for multinational, data-driven studies.

Main Results:

• Conflicting results exist regarding COVID-19 mortality in SRD patients.
• Evidence suggests variations in mortality rates across different SRDs.
• Disease activity, duration, medication, and comorbidities appear to influence COVID-19 outcomes in SRD patients.

Conclusions:

• An individualized risk assessment is necessary for SRD patients contracting COVID-19.
• Factors such as SRD type, disease activity, and comorbidities must be incorporated into risk calculations.
• Further multinational research is warranted to comprehensively understand and stratify COVID-19 risks in diverse SRD populations.